Search Results - "GUAZA, Carmen"
-
1
Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
Published in PloS one (19-09-2018)“…Extracellular vesicles (EVs) have emerged as important mediators of intercellular communication and as possible therapeutic agents in inflammation-mediated…”
Get full text
Journal Article -
2
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis
Published in International journal of molecular sciences (19-11-2022)“…Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune and degenerative disease with axonal damage and demyelination as its main features. Its dual…”
Get full text
Journal Article -
3
Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis
Published in Neurotherapeutics (01-04-2021)“…Summary Gut microbiome studies in multiple sclerosis (MS) patients are unravelling some consistent but modest patterns of gut dysbiosis. Among these, a…”
Get full text
Journal Article -
4
Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis
Published in Neurobiology of disease (01-09-2020)“…Multiple Sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes in the spinal cord and the brain. Natural and…”
Get full text
Journal Article -
5
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Published in Angewandte Chemie International Edition (08-12-2014)“…Monoacylglycerol lipase (MAGL) is the enzyme responsible for the inactivation of the endocannabinoid 2‐arachidonoylglycerol (2‐AG). MAGL inhibitors show…”
Get full text
Journal Article -
6
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Published in Frontiers in cellular neuroscience (19-02-2020)“…The consistency, efficacy, and safety of cannabis-based medicines have been demonstrated in humans, leading to the approval of the first cannabis-based therapy…”
Get full text
Journal Article -
7
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation
Published in Glia (01-09-2012)“…The endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS)…”
Get full text
Journal Article -
8
Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
Published in Frontiers in immunology (14-06-2019)“…Gut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the…”
Get full text
Journal Article -
9
Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis
Published in Journal of neuroinflammation (19-03-2020)“…The participation of microglia in CNS development and homeostasis indicate that these cells are pivotal for the regeneration that occurs after demyelination…”
Get full text
Journal Article -
10
2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
Published in Glia (01-07-2018)“…The innate immune response is mediated by primary immune modulators such as cytokines and chemokines that together with immune cells and resident glia…”
Get full text
Journal Article -
11
Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system
Published in Current pharmaceutical design (01-01-2014)“…The central nervous system (CNS) innate immune response includes an arsenal of molecules and receptors expressed by professional phagocytes, glial cells and…”
Get more information
Journal Article -
12
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
Published in Journal of neuroinflammation (01-03-2018)“…Multiple sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes variously dominant in different stages of the…”
Get full text
Journal Article -
13
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
Published in PloS one (01-04-2014)“…Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases. A cannabigerol…”
Get full text
Journal Article -
14
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
Published in Gut microbes (09-11-2020)“…A growing number of studies support that the bidirectional interactions between the gut microbiota, the immune system and the CNS are relevant for the…”
Get full text
Journal Article -
15
CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model
Published in Journal of neuroinflammation (18-02-2016)“…Interaction of CD200 with its receptor CD200R has an immunoregulatory role and attenuates various types of neuroinflammatory diseases. Immunofluorescence…”
Get full text
Journal Article -
16
A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
Published in Cells (Basel, Switzerland) (07-04-2020)“…Previous studies in experimental autoimmune encephalomyelitis (EAE) models have shown that some probiotic bacteria beneficially impact the development of this…”
Get full text
Journal Article -
17
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
Published in Brain, behavior, and immunity (01-05-2011)“…Research highlights ► Anandamide downregulates IL-12p70 and IL-23 in TMEV-IDD influencing adaptive immunity. ► TMEV-infected microglia is a target for…”
Get full text
Journal Article -
18
The endocannabinoid system is modulated in response to spinal cord injury in rats
Published in Neurobiology of disease (01-01-2009)“…Abstract Endocannabinoids are lipid mediators with protective effects in many diseases of the nervous system. We have studied the modulation of the…”
Get full text
Journal Article -
19
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide
Published in The European journal of neuroscience (01-08-2008)“…Cannabinoids have recently been approved as a treatment for pain in multiple sclerosis (MS). Increasing evidence from animal studies suggests that this class…”
Get full text
Journal Article -
20
Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling
Published in British journal of pharmacology (01-06-2005)“…1 Cannabinoid (CB) receptor agonists have potential utility as anti‐inflammatory drugs for the treatment of many disease conditions. In the present study, we…”
Get full text
Journal Article